OncoDNA SA
20.6 FTEThe score of OncoDNA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -74 % Headcount (avg FTE) -35 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
OncoDNA's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −€3.79m | ||||
| Equity | −256,642 € | ||||
| Cash | 520,609 € | ||||
| EBITDA | −484,856 € | ||||
| Total assets | €5.27m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
OncoDNA's financial analysis
- Solvency-4.9%sector median: 65.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of OncoDNA
OncoDNA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0501.631.837
- VAT number
- BE0501631837
- Peppol
- Registered · 0208:0501631837 · as of 31 Oct 2026
- Legal form
- SA
- Incorporated
- 29 Nov 2012
- Registered office
- 6041 Charleroi
- Size
- Small · 20.6 FTE
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
OncoDNA (SA) has been based in Charleroi since 2012, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net loss of €3.79m and equity of −256,642 €; its revenue is not published. With 20.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -4.9%, below the median of its sector (65.6%).
Companies similar to OncoDNA
Companies in the same business, of comparable size and area, outside its group.
- ECG Labs Activities of holding companies Lummen · balance sheet €2.64m
- BIO.BE Diagnostic imaging services and medical laboratory activities Charleroi · balance sheet €3.04m
- Artsenpraktijk Sithova Diagnostic imaging services and medical laboratory activities Leuven · balance sheet €3.20m
- V.H.V. Diagnostic imaging services and medical laboratory activities Temse · balance sheet €6.81m
- VAN Goethem Diagnostic imaging services and medical laboratory activities Sint-Niklaas · balance sheet €3.59m
- Centre d'Imagerie Médicale de Gembloux Diagnostic imaging services and medical laboratory activities Gembloux · balance sheet €2.83m
- L.B.A. Diagnostic imaging services and medical laboratory activities Londerzeel · balance sheet €2.53m
- Burssens Diagnostic imaging services and medical laboratory activities Aarschot · balance sheet €2.50m
Frequently asked questions about OncoDNA
What is the revenue of OncoDNA?
OncoDNA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of OncoDNA?
In Belgium, the VAT number is the company number prefixed with BE: BE0501631837 for OncoDNA, if the company is VAT-registered. Its company number (CBE) is 0501.631.837.
Where is the registered office of OncoDNA?
According to the CBE register, the registered office of OncoDNA is in 6041 Charleroi.
What is the equity of OncoDNA?
At the close of the 2025 financial year, the equity of OncoDNA amounts to -256,642 €, a solvency of -4.9% of total assets.
How many people work at OncoDNA?
20.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages OncoDNA?
The register lists 10 active mandates at OncoDNA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of OncoDNA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →